Results 101 to 110 of about 1,043 (244)

Therapist‐Guided Smartphone‐Based Aftercare for Inpatients With Severe Anorexia Nervosa (SMART‐AN): A Randomized Clinical Trial

open access: yesInternational Journal of Eating Disorders, EarlyView.
ABSTRACT Objective To evaluate the efficacy of a 16‐week therapist‐guided, smartphone‐based aftercare intervention as an add‐on to treatment as usual (TAU) following inpatient treatment for anorexia nervosa (AN). Method In this single‐center randomized clinical trial, 186 female inpatients with DSM‐5 AN (≥ 13 years; body mass index (BMI) ≥ 15.0 kg/m2 ...
Sandra Schlegl   +4 more
wiley   +1 more source

Longitudinal Residential Eating Disorder Treatment Outcomes for Binge‐Eating Disorder When Using the Unified Treatment Model

open access: yesInternational Journal of Eating Disorders, EarlyView.
ABSTRACT Objective Despite its prevalence, research on binge‐eating disorder (BED) outcomes for residential treatment remains limited. To address this research scarcity, we evaluated changes in ED behaviors and comorbid symptoms, including depression and anxiety, for patients with BED that received residential eating disorder (ED) care from a ...
Kiki M. Kline   +3 more
wiley   +1 more source

Neurocognitive and emotional benefits of choir singing and their mediating factors across adulthood. [PDF]

open access: yesAging Clin Exp Res
Moisseinen N   +6 more
europepmc   +1 more source

Comparative Properties of Two Self‐Report Measures of Avoidant/Restrictive Food Intake Disorder: Psychometric and Clinical Utility

open access: yesInternational Journal of Eating Disorders, EarlyView.
ABSTRACT Objectives We compared two measures of Avoidant/Restrictive Food Intake Disorder (ARFID)—the NIAS and the PARDI‐AR‐Q to determine which demonstrates better psychometric and clinical utility. Methods The study was pre‐registered (OSF; DOI 10.17605/OSF.IO/N8WBF). Participants (aged ≥ 18 years, BMI > 18.5) were recruited via Prolific and screened
Rebecca Nicholls‐Clow   +2 more
wiley   +1 more source

Cilostazol in patients with heart failure and preserved ejection fraction—The CLIP‐HFpEF trial

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1437-1446, April 2025.
• Cilostazol is an oral PDE‐3 inhibitor that may have advantageous effects in heart failure with preserved ejection fraction (HFpEF). • Cilostazol significantly improved short‐term heart failure‐related health status scores (KCCQ‐12) and NT‐proBNP levels when compared to placebo.
Norman Aiad   +9 more
wiley   +1 more source

Who is using continuous glucose monitoring for type 2 diabetes management? A scoping review protocol. [PDF]

open access: yesBMJ Open
Kragen B   +6 more
europepmc   +1 more source

Nanophotonic Biosensors and the Paradigm of Trans‐Scale Autonomous Bio‐Integrated Diagnostics for Addressing Health Complexities

open access: yesElectron, EarlyView.
Physics‐driven advances in optical nanobiosensors for rapid, miniaturized, and point‐of‐care diagnostics for next‐generation decentralized and personalized healthcare based on sensor intelligence. ABSTRACT Public health emergencies and the escalating burden of chronic diseases necessitate a paradigm shift from centralized laboratory testing to rapid ...
Vishal Chaudhary   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy